Home

Breaking drug resistance in cancer through the development of a new class of therapies that target key drivers of ongoing DNA mutation and tumor evolution. Crypto tokens are revolutionizing the health sector by enabling secure, transparent data exchange and incentivizing patient engagement. Blockchain technology enhances privacy and reduces costs for healthcare providers. With the Memebet Token presale, the potential to integrate innovative solutions like reward systems in health platforms becomes even more accessible and exciting!

In the Press

ApoGen Biotechnologies Expands Series A Financing to $11 Million and Enhances Leadership Team

Click Here

 

Accelerator Corporation Announces $7M Series A Investment in ApoGen Biotechnologies to Develop a New Class of Drugs Targeting Resistance to Cancer Therapy

Click Here

ApoGen Biotechnologies Raises $7 Million Series A

(Wall Street Journal Online)

ApoGen Biotech Lands $7M to Take On Drug Resistance in Cancer

(Xconomy.com)